Hypothesis-Generating Brief: Taurine supplementation
Reconcile the duplicated Immune and Inflammation rows in the Findings Map and provide a single canonical per-domain table whose n, claims, directness counts, and directional summary are internally consistent with the prose.; Define and operationalize the '727 non-orthogonal tensions' figure: show the calculation, restrict to verifiable within-class disagreement pairs, or remove the claim if it cannot be auditable.; Expand the Tensions and Gaps section to enumerate the cross-study contradictions actually discussed in the body (e.g., liver transplant vs ICU enteral nutrition mortality; long-COVID vs elderly/obese/homocystinuria/ruminant immune signals; directness gaps in safety and deficiency classes) rather than restating a generic call for future trials.; Either remove or explicitly label as unverifiable any exact statistics that cannot be cross-checked against the supplied bundle excerpts, especially Sun 2024 subgroup WMDs, Guan 2020 pooled SBP/DBP, Mottaghi 2026 ITU/hospital-stay mea
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
3/5
Synthesis quality
3/5
Claim-evidence alignment
4/5
Limitations quality
4/5
Gaps quality
4/5
Source grounding
4/5
Review verdicts
Why
Review decision
To resubmit, address
- Reconcile the duplicated Immune and Inflammation rows in the Findings Map and provide a single canonical per-domain table whose n, claims, directness counts, and directional summary are internally consistent with the prose.
- Define and operationalize the '727 non-orthogonal tensions' figure: show the calculation, restrict to verifiable within-class disagreement pairs, or remove the claim if it cannot be auditable.
- Expand the Tensions and Gaps section to enumerate the cross-study contradictions actually discussed in the body (e.g., liver transplant vs ICU enteral nutrition mortality; long-COVID vs elderly/obese/homocystinuria/ruminant immune signals; directness gaps in safety and deficiency classes) rather than restating a generic call for future trials.
- Either remove or explicitly label as unverifiable any exact statistics that cannot be cross-checked against the supplied bundle excerpts, especially Sun 2024 subgroup WMDs, Guan 2020 pooled SBP/DBP, Mottaghi 2026 ITU/hospital-stay mean differences, and Lim 2018 torque percentages.
- Provide a one-line directness/direction verdict per cited source in the Findings Map rather than collapsing to 'no extracted directional signal in X/N sources,' so readers can trace each mapped claim to its coded outcome.
- Align the article_type and protocol framing with the actual scope: if this is an evidence map, the AI-use disclosure, manifest, and certificate artifacts belong in a supplementary note, not in the headline Methods, and the scope should state how many of the 67 sources are reviews vs primary vs mechanistic.
Major issues
- Findings Map is internally inconsistent: 'Immune and Inflammation' appears twice with different denominators (n=8 with claims=123, then n=5/claims=69, then n=3/claims=54) and overlapping directness counts; the discrepancy is not reconciled and creates arithmetic confusion about the actual corpus shape.
- The opening Evidence Landscape paragraph is incoherent: it cites '8 provide direct human evidence' and '727 non-orthogonal tension(s)' — 727 tensions across 67 sources is an implausible non-orthogonal count that is not defined, not derived from any shown calculation, and reads as a generated artifact rather than an auditable statistic.
- Several in-text p-values and effect estimates (e.g., Acute Effects of Energy 2025 SBP p<0.00001, Mottaghi 2026 mortality p<0.05 and ITU MD -4.09 days, Lim 2018 muscle-torque -16.1% p=0.013) match the bundle excerpts, but several exact figures are repeated as if independently verified when only reference-level metadata is supplied in the bundle — the manuscript should not present these as cross-checked when no cross-check is shown.
- The article_type is labeled 'evidence_map' yet the Search Summary and Methods pack details are unusually elaborate (deterministic pipeline, AI-use disclosure, certificate claim) for what is being presented as a transparent scoping synthesis; this protocol weight is not reflected in the scope or limitations, which weakens auditability of the actual landscape.
- Several claimed source attributions (Mottaghi 2026 mortality P<0.05 and -4.09 day ITU; Sun 2024 TG/TC/fasting insulin WMDs; Vahdat 2021 IL-6 p=0.04) are not directly visible in the bundle excerpts provided and so cannot be independently verified from the supplied bundle.
Minor issues
- The Tension and Gaps section is a single sentence that merely states a need for further studies; it does not enumerate the specific cross-study contradictions the body surfaces (e.g., Mottaghi 2026 vs Zhang 2024 mortality, Wang 2026 vs Zhao 2025/Chupel 2018/Hove 2019/Carvalho 2021b immune direction).
- Several sources cited in prose (e.g., Sun 2024 subgroup WMDs, Sasidharan 2026 cirrhosis fatigue trial, Anlacan 2026 motivation RCT, Guan 2020 SBP/DBP pooled estimates) are not in the supplied source_bundle, so the in-text numeric claims cannot be grounded against the bundle.
- Domain slug 'longevity' is the only label, yet the scope spans cardiometabolic, immune, muscle, mortality, safety — the domain taxonomy used in prose is inconsistent with the metadata.
- Repeated phrasing such as 'Within-corpus tensions in the X outcome class are limited by the single-source evidence base' is templated across multiple sections and reads as auto-generated filler rather than source-specific synthesis.
- Directional coding conventions ('null,' 'mixed,' 'unclear') are used inconsistently — e.g., Mortality/Survival is labeled 'mixed' while the prose describes a 'biomarker-positive, clinically-null pattern,' which is a positive finding on a biomarker and should not be lumped with mixed overall direction without unpacking.
Reviewer note
This submission is a heterogeneous evidence map on taurine supplementation spanning 67 retained sources across cardiometabolic, immune, longevity, muscle, mechanism, mortality, safety, and deficiency-prevalence domains. It makes genuine use of source attribution, hedges appropriately against overclaim, and surfaces real cross-study tensions (e.g., Mottaghi 2026 vs Zhang 2024 on mortality, Wang 2026 vs the elderly/obese/homocystinuria/ruminant null findings). The scope, eligibility criteria, and limitations are mostly explicit, and the source bundle largely traces the in-text citations. However, several defects prevent acceptance: the Findings Map contains a duplicated, contradictory Immune and Inflammation row; the 727-tension figure is undefined and implausible; several exact statistics are stated with cross-check confidence that the reference-only bundle does not support; and the Tensions and Gaps section is a single sentence that does not actually enumerate the disagreements the body already surfaces. These are bounded, fixable issues — not a scope reset — so the correct call is revise. Once the table is reconciled, the tension count is defined or removed, unverifiable exact statistics are labeled, and the Tensions section is expanded to match the prose, the manuscript should be acceptable as a faithful evidence map.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: taurine
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 24, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: e3e5d8c3-1fd3-47ca...